DTDavid Thomas — no licensed photograph is available, so the sector leader plate is shown instead.

Sector leader

David Thomas

Head of Policy and Public Affairs at Alzheimer's Research UK

Press citations

4

Topic

1

Dementia

Last quoted

Sept 2026

David Thomas: key facts

Kind of voice
Sector leader
Role
Head of Policy and Public Affairs at Alzheimer's Research UK
Quoted on
Dementia
Tracked press citations
4
Most recently quoted
30 Sept 2026

“Today's ruling is an opportunity for NICE to consider the real cost of Alzheimer's on people and their families, and we welcome the decision to look again at whether new medicines could be provided on the NHS.”

What David Thomas has said

  • “While these treatments offer modest benefits and can cause serious side effects, they provide the foundation for a future where dementia becomes a treatable condition. Now, we need NICE to look again at how these medicines could benefit both people with early Alzheimer's and their carers.”

    head of policy and public affairs, Alzheimer's Research UK · Dementia · 30 Sept 2026 · Appeal finds NICE must reconsider Alzheimer's drugs ↗

  • “These blood tests had 'huge potential', as they were less invasive, relatively inexpensive and more scalable than existing tests such as positron emission tomography (PET) scans and spinal fluid sampling.”

    Head of policy and public affairs at the Alzheimer's Research UK charity · Dementia · 30 Sept 2026 · Scientists shed new light on Alzheimer’s warning signs ↗

  • “High-quality studies like this are crucial to enhancing our understanding of how blood tests for Alzheimer's could be used in clinical practice. We need to generate more evidence so we can use these tests in the NHS.”

    head of policy and public affairs at Alzheimer's Research UK · Dementia · 27 Aug 2026 · Study finds 10% of over-70s in UK could have Alzheimer’s-like changes in brain ↗

Where David Thomas has been quoted

  1. NHS spending watchdog to review evidence on Alzheimer’s treatmentsalzheimersresearchuk.org · 30 Sept 2026
  2. Appeal finds NICE must reconsider Alzheimer's drugspharmaphorum.com · 30 Sept 2026
  3. Scientists shed new light on Alzheimer’s warning signsft.com · 30 Sept 2026
  4. Study finds 10% of over-70s in UK could have Alzheimer’s-like changes in braintheguardian.com · 27 Aug 2026

Related media coverage

Recent UK press coverage of their topics — not necessarily citing them directly.

Chief executives, directors and spokespeople of trade bodies, representative associations and charities speaking for the sector. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.